Literature DB >> 212193

Human breast carcinoma cells in continuous culture: a review.

L W Engel, N A Young.   

Abstract

A comprehensive listing of putative human breast carcinoma cell lines and the extent to which each has been characterized is presented. Criteria used to certify the human, mammary, and malignant origin of a cell line include: (a) a reliable histopathological diagnosis; (b) interspecies specificity established by human karyotype, isoenzyme profiles, and/or cell surface antigenicity; (c) intraspecies specificity, demonstrated by genetic evidence of a unique, human donor distinct from other cells including HeLa cells; and (d) organ specficity, supported by morphological evidence of epithelial structure and secretory activity, and especially by the expression of differentiated functions; these include presence of receptors for sex steroid hormones, hormone responsiveness, and production of milk proteins, fatty acids, or milk-specific antigens. Of the 47 cell lines for which data are here reported, 22 have been shown to be derived from human non-HeLa donors and to have epithelial morphology as revealed by light or electron microscopy. Differentiated function has been recorded for 19 cell lines. Additional human breast cancer cell lines have been reported, but characterization of some of these has been insufficient to judge the legitimacy of their predigrees. For others mammary origin is questionable. Six purported breast cell lines are in reality HeLa cells, and one is of nonhuman origin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212193

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  92 in total

1.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.

Authors:  O W Petersen; L Rønnov-Jessen; A R Howlett; M J Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples.

Authors:  J T Emerman; D A Wilkinson
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

3.  Establishment and characterization of a new cell line (VHB-1) derived from a primary breast carcinoma.

Authors:  B Vandewalle; M Collyn d'Hooghe; J B Savary; M O Vilain; J P Peyrat; M Deminatti; A Delobelle-Deroide; J Lefebvre
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors.

Authors:  Adam F Prasanphanich; Lauren Retzloff; Stephanie R Lane; Prasant K Nanda; Gary L Sieckman; Tammy L Rold; Lixin Ma; Said D Figueroa; Samantha V Sublett; Timothy J Hoffman; Charles J Smith
Journal:  Nucl Med Biol       Date:  2009-02       Impact factor: 2.408

Review 5.  Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

6.  Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin.

Authors:  U M Wewer; L A Liotta; M Jaye; G A Ricca; W N Drohan; A P Claysmith; C N Rao; P Wirth; J E Coligan; R Albrechtsen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures.

Authors:  Jean J Latimer; Tariq Nazir; Lisa C Flowers; Michael J Forlenza; Kelly Beaudry-Rodgers; Crystal M Kelly; Julie A Conte; Kenneth Shestak; Amal Kanbour-Shakir; Stephen G Grant
Journal:  Exp Cell Res       Date:  2003-11-15       Impact factor: 3.905

8.  MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo.

Authors:  Y Liu; D el-Ashry; D Chen; I Y Ding; F G Kern
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

9.  Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line.

Authors:  C Natoli; G Sica; V Natoli; A Serra; S Iacobelli
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

10.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.

Authors:  F R Ahmann; H S Garewal; R Schifman; A Celniker; S Rodney
Journal:  In Vitro Cell Dev Biol       Date:  1987-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.